Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
FRANCE – ABL Biotechnologies, a South Korean biotechnology firm, has signed a global licensing and exclusive collaboration agreement with Sanofi to develop and commercialize a new Parkinson’s disease therapy candidate.…
Read More
UNITED KINGDOM – GSK and Oxford have launched a five-year collaboration aimed at accelerating R&D breakthroughs in a variety of difficult-to-treat diseases such as Alzheimer’s and Parkinson’s through the use…
Read More
BELGIUM – Novartis is putting US$150 million into a Parkinson’s disease drug candidate that is competing with drugs in development at companies such as Roche and AstraZeneca. Novartis will pay…
Read More